2006
DOI: 10.1097/00000542-200604000-00009
|View full text |Cite
|
Sign up to set email alerts
|

Reversal of Rocuronium-induced Neuromuscular Block by the Selective Relaxant Binding Agent Sugammadex

Abstract: At doses of 2.0 mg/kg or greater, sugammadex safely reversed 0.6 mg/kg rocuronium-induced neuromuscular block in a dose-dependent manner. Sugammadex enhanced renal excretion of rocuronium and was excreted unchanged by the kidneys.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

13
231
2
9

Year Published

2007
2007
2017
2017

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 321 publications
(255 citation statements)
references
References 24 publications
13
231
2
9
Order By: Relevance
“…Jones and Turkstra raised the intriguing question of whether the administration of sugammadex (a selective binding agent that encapsulates rocuronium [1]) mitigates ongoing anaphylaxis due to rocuronium [2]. They speculated that sugammadex might remove free rocuronium molecules from the circulation, and hence slow down or halt the allergic reaction.…”
mentioning
confidence: 99%
“…Jones and Turkstra raised the intriguing question of whether the administration of sugammadex (a selective binding agent that encapsulates rocuronium [1]) mitigates ongoing anaphylaxis due to rocuronium [2]. They speculated that sugammadex might remove free rocuronium molecules from the circulation, and hence slow down or halt the allergic reaction.…”
mentioning
confidence: 99%
“…It is not certain whether the IgE antibodies form a homogeneous group: it is likely that more than one sensitising agent may be involved. The plasma half-life of the sugammadex-rocuronium complex exceeds that of the naked rocuronium molecule [2] and, if the allergenic determinant remains exposed despite the embracing sugammadex molecule, the allergenic determinant may persist in the circulation for longer than would otherwise be the case, with the attendant possibility of exacerbating the anaphylactic reaction.…”
Section: A Replymentioning
confidence: 99%
“…[8][9][10][11] One may criticize the studies because of the choice of accelerometry, which overestimates the degree of recovery, but this drawback is minor considering how effective sugammadex is compared with either placebo or neostigmine. In most clinical circumstances, the time interval from blockade until full recovery is not expected to be particularly critical.…”
mentioning
confidence: 99%
“…[8][9][10][11] Dans ces études, on peut critiquer le choix de l'accélérométrie, qui surestime le niveau de récupération, mais ce problème est mineur quand on constate l'efficacité remarquable du sugammadex comparée soit au placebo, soit à la néostigmine. En pratique, l'intervalle entre la curarisation et la récupération complète ne devrait pas être d'une importance cruciale.…”
unclassified
See 1 more Smart Citation